Industry News

Our news page will keep you informed of press releases and news articles on rapid and alternative microbiological method technologies and updates from technology suppliers.

Please click here to submit your news.

Life Technologies Sets New Workflow Standard in Detection of Common Contaminants in Biopharmaceutical Manufacturing

Life Technologies Corporation announced a program that streamlines the detection of three common contaminants of mammalian cell culture-based biopharmaceutical manufacturing. The Applied Biosystems Cell Culture Rapid Methods Program applies core technologies from across the company to combine one sample preparation step with one instrument platform for real-time PCR based detection of Mycoplasma, Vesivirus 2117 and Mouse Minute Virus (MMV). Mycoplasma, Vesivirus 2117 and MMV are DNA and RNA-based potential contamination threats in mammalian cell culture production.

Because of its high accuracy and rapid same-day results, the Cell Culture Rapid Methods Program helps enable in-process testing for these contaminants at multiple points along the biopharmaceutical manufacturing process. These biologic detection kits are highly sensitive and accurate tests that enable the quick isolation and detection of these known contaminants from cell culture samples. The improved protocol for PrepSEQ™ 1-2-3 Nucleic Acid Extraction Kit can extract nucleic acid for all three contaminants from a single cell culture, in order to speed the detection of a multiple number of organisms. Sample preparation and detection of all three contaminants can be performed in less than seven hours. It is expected that biopharmaceutical companies will use the program to detect potential contamination early in production, safeguarding the manufacturing processes.

Post a Comment

Previous Post Next Post

Contact Form